Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
![]()
Reuters Newmedia - Thursday December 28, 2000
Gene Emery
The new study focused on Streptococcus pneumoniae, the most commonly identified cause of meningitis, pneumonia and middle ear infections in the United States. The findings illustrated that the risk of developing an antibiotic-resistant bacterial infection rose substantially between 1995 and 1998.
Among those who developed a Streptococcus pneumoniae infection, 14 percent in 1998 had one resistant to at least three different types of antibiotics, compared to 9 percent in 1995.
''Multidrug-resistant pneumococci are common and are increasing,'' said the research team, led by Dr. Cynthia Whitney of the U.S. Centers for Disease Control and Prevention in Atlanta.
Millions Of Pounds Of Antibiotics Consumed Annually
About 160 million antibiotic prescriptions are written in the United States each year for some 25 million pounds (11.3 million kg) of antibiotics. About half of those prescriptions are unnecessary, according to an editorial in the Journal.
Animals are fed a similar amount of antibiotics.
The new study's findings were based on tests of 3,475 samples from 1998 from all over the country. Twenty-four percent of the bacteria in the samples were resistant to penicillin, and the rate ranged up to 35 percent in Tennessee and down to 15 percent in New York and California. Once the bacteria had adapted to fight off penicillin, the researchers found, they were likely to be able to withstand the onslaught of other types of antibiotics as well.
One answer, researchers said, is to take greater care in the use of the drugs, which are so common they are often included in the food of livestock.
Another is to immunize people against pneumococcal infections through vaccination. The vaccine, already used for adults, recently has become available to young children in the United States.
In their editorial, Drs. Richard Wenzel and Michael Edmond of Virginia Commonwealth University in Richmond said routinely immunizing infants in the United States would prevent 53,000 cases of pneumonia, 12,000 cases of meningitis and 110 deaths each year.
The elderly and those with weak immune systems also face a high risk of death or illness from pneumococcal infections.
''We need to reassess policies on antibiotic use while changing our approach to include vaccinations against pneumococcal infections of all children over the age of 4, all adults over age 65, and all people with HIV infection,'' Wenzel and Edmond said.
001228
RE001237
Copyright © 2000 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .